43.83
Guardian Pharmacy Services Inc stock is traded at $43.83, with a volume of 698.57K.
It is up +1.01% in the last 24 hours and up +5.69% over the past month.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
See More
Previous Close:
$43.39
Open:
$43.23
24h Volume:
698.57K
Relative Volume:
1.72
Market Cap:
$2.78B
Revenue:
$1.46B
Net Income/Loss:
$53.23M
P/E Ratio:
52.47
EPS:
0.8353
Net Cash Flow:
$70.01M
1W Performance:
+9.22%
1M Performance:
+5.69%
6M Performance:
+30.25%
1Y Performance:
+51.24%
Guardian Pharmacy Services Inc Stock (GRDN) Company Profile
Name
Guardian Pharmacy Services Inc
Sector
Industry
Phone
(404) 810-0089
Address
300 GALLERIA PARKWAY SE, ATLANTA
Compare GRDN vs HCA, THC, EHC, FMS, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GRDN
Guardian Pharmacy Services Inc
|
43.83 | 2.75B | 1.46B | 53.23M | 70.01M | 0.8353 |
|
HCA
Hca Healthcare Inc
|
421.21 | 91.33B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
263.46 | 21.67B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
121.04 | 11.99B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.23 | 11.88B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
DVA
Davita Inc
|
181.33 | 11.68B | 13.84B | 1.10B | 1.49B | 10.42 |
Guardian Pharmacy Services Inc Stock (GRDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-26 | Initiated | BofA Securities | Buy |
| Mar-30-26 | Initiated | Jefferies | Buy |
| Oct-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Outperform |
| Oct-21-24 | Initiated | Truist | Buy |
Guardian Pharmacy Services Inc Stock (GRDN) Latest News
Guardian Pharmacy Implements Insider Lock-Up to Support Stability - TipRanks
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Maintains Target Price $47 - Moomoo
Guardian Pharmacy acquires assets from Nautilus Pharmacy - Investing.com
Guardian Pharmacy acquires assets from Nautilus Pharmacy By Investing.com - Investing.com South Africa
Guardian Pharmacy Services Acquires Assets Of Tennessee-Based Nautilus Pharmacy - TradingView
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy - Yahoo Finance
Guardian Pharmacy Surges as Earnings Beat Fuels Rally - TipRanks
Guardian (GRDN) Quarterly Figures: EPS Clears the Reported Estimate; Price Move - vinanet.vn
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 GuidanceLearn Why - simplywall.st
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript - AOL.com
Guardian Pharmacy CEO to join a Sept. 15 fireside chat for investors - Stock Titan
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference - Yahoo Finance Singapore
Guardian Pharmacy Stock Sinks As IRA Fears Bite - TipRanks
GRDN Q2 2026 Earnings: EPS Beats by 21.65% as Revenue Picture Remains UnclearEPS Growth Rate - vinanet.vn
Guardian Pharmacy Services opens first location in Kentucky - McKnight's Senior Living
Guardian Pharmacy Services Lifts 2026 Earnings Outlook - TipRanks
Guardian Pharmacy Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
GRDN Q2 2026 Earnings: EPS of $0.34 Beats Estimates by 21.65%Profit Margin Analysis - Vinanet
GRDN Q2 2026 Earnings: 21.65% EPS Beat Overshadowed by 4.85% Stock DeclineGuidance Downgrade Alert - Vinanet
Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5.5%Should You Sell? - MarketBeat
Guardian Pharmacy Slides as Profit-Takers Exit Rally - TipRanks
Janus Henderson Group PLC Trims Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
Dimensional Fund Advisors LP Acquires 139,070 Shares of Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
GRDN Q2 2026 Earnings: EPS Beats Estimates by 21.65% as Shares Slip 2.6%Guidance Downgrade Alert - vinanet.vn
Guardian Pharmacy Services (GRDN) Falls 5.38% Toward Key Support at $39.4Covered Call Trade - vinanet.vn
Guardian Pharmacy Services (GRDN) As Strong Results And Higher Outlook Recast The Valuation Story - Yahoo Finance
Earnings Beat: Guardian Pharmacy Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Guardian Pharmacy Services Q2 Earnings Call Highlights - sharewise.com
Why Guardian Pharmacy Services (GRDN) Is Up 10.9% After Raising 2026 Revenue Guidance And Expanding Footprint - Yahoo Finance
Guardian Pharmacy Services (NYSE:GRDN) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Analysts Conflicted on These NA Names: Starz Entertainment Corp (STRZ), Guardian Pharmacy Services, Inc. Class A (GRDN) and MSC Income Fund, Inc. (MSIF) - The Globe and Mail
Guardian Pharmacy Services stock hits all-time high at 44.47 USD By Investing.com - Investing.com India
Guardian Pharmacy Services stock hits all-time high at 44.47 USD - Investing.com UK
Guardian Pharmacy Services, Inc. Stock 12‑Month Price Target Raised to $48.83, Implies 24% Upside - TradingView
Guardian Pharmacy Stock Pops On Raised 2026 Outlook - TipRanks
Guardian Pharmacy Services (NYSE:GRDN) Sets New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Oppenheimer Adjusts PT on Guardian Pharmacy Services to $49 From $43, Maintains Outperform Rating - marketscreener.com
Guardian Pharmacy Services Raises 2026 Outlook After Strong Second Quarter - Yahoo Finance
Oppenheimer Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $49 - Moomoo
Why is Guardian Pharmacy Services stock rallying today? By Investing.com - Investing.com Canada
Earnings call transcript: Guardian Pharmacy lifts 2026 outlook on Q2 margin gains - Investing.com Nigeria
Guardian Pharmacy Services shares rise 3% on guidance beat By Investing.com - Investing.com Canada
Guardian Pharmacy Services shares rise 3% on guidance beat - Investing.com
Guardian Pharmacy Services Inc (GRDN) (Q2 2026) Earnings Call Highlights: Raised Guidance and ... - Yahoo Finance UK
Guardian Pharmacy Services, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates - Yahoo! Finance Canada
Guardian Pharmacy: Q2 Earnings Snapshot - AOL.com
Guardian Pharmacy Services, Inc. 3Q 2026: Revenue $351.8M, EPS $0.34— 10-Q Summary - TradingView
Guardian Pharmacy Q2 revenue beats estimates; 2026 outlook lifted - TradingView
Guardian Pharmacy (NYSE: GRDN) lifts 2026 revenue and EBITDA outlook - Stock Titan
Guardian Pharmacy Services Inc Stock (GRDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):